Adam Oskowitz, MD

Vascular surgeon

Adam Oskowitz is interested in developing novel treatments for aortic aneurysms using stem cells. He has extensive experience in the evaluation and care of patients in the outpatient and inpatient setting as well as the planning and performance of basic and complex cases involving vascular disease.

Oskowitz earned a master's degree in public health at Dartmouth College in 2001, then went on to earn medical and doctorate degrees from Tulane University between 2002 and 2009. He completed his surgery internship and residency at UCLA, where he served as chief resident of general surgery from 2013 to 2014. He also completed as fellowship in vascular surgery at UCLA in 2016. Oskowitz is an assistant professor of surgery at UCSF.


Vascular and Endovascular Surgery
400 Parnassus Ave., Suite 501
San Francisco, CA 94143
Phone: (415) 353-2357
Fax: (415) 353-2669

Hours: Monday to Friday
8 a.m. – 5 p.m.

Board Certification

Surgery, American Board of Surgery

Academic Title

Assistant Professor

More about Adam Oskowitz


Tulane University School of Medicine 2009


UCLA Medical Center 2014


UCLA Medical Center 2016

Selected Research and Publications

  1. Rollo JC, Farley SM, Oskowitz AZ, Woo K, DeRubertis BG. Contemporary outcomes after venography-guided treatment of patients with May-Thurner syndrome. J Vasc Surg Venous Lymphat Disord. 2017 Sep; 5(5):667-676.e1.
  2. Rollo JC, Farley S, Oskowitz A, Chow W, Jimenez JC, Derubertis B. Contemporary Outcomes of Elective Iliac Vein Stenting in Chronic Venous Occlusive Disease. J Vasc Surg. 2016 Aug; 64(2):542.
  3. Oskowitz AZ, Archie M, Archie M, Quinones-Baldrich W. Hybrid treatment of aortic arch aneurysms. J Cardiovasc Surg (Torino). 2015 Oct; 56(5):719-28.
  4. Oskowitz AZ, Penfornis P, Tucker A, Prockop DJ, Pochampally R. Drosha regulates hMSCs cell cycle progression through a miRNA independent mechanism. Int J Biochem Cell Biol. 2011 Nov; 43(11):1563-72.
  5. Sanchez CG, Penfornis P, Oskowitz AZ, Boonjindasup AG, Cai DZ, Dhule SS, Rowan BG, Kelekar A, Krause DS, Pochampally RR. Activation of autophagy in mesenchymal stem cells provides tumor stromal support. Carcinogenesis. 2011 Jul; 32(7):964-72.
  6. Shoji M, Oskowitz A, Malone CD, Prockop DJ, Pochampally R. Human mesenchymal stromal cells (MSCs) reduce neointimal hyperplasia in a mouse model of flow-restriction by transient suppression of anti-inflammatory cytokines. J Atheroscler Thromb. 2011; 18(6):464-74.
  7. Oskowitz A, McFerrin H, Gutschow M, Carter ML, Pochampally R. Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic. Stem Cell Res. 2011 May; 6(3):215-25.
  8. Sanchez C, Oskowitz A, Pochampally RR. Epigenetic reprogramming of IGF1 and leptin genes by serum deprivation in multipotential mesenchymal stromal cells. Stem Cells. 2009 Feb; 27(2):375-82.
  9. Oskowitz AZ, Lu J, Penfornis P, Ylostalo J, McBride J, Flemington EK, Prockop DJ, Pochampally R. Human multipotent stromal cells from bone marrow and microRNA: regulation of differentiation and leukemia inhibitory factor expression. Proc Natl Acad Sci U S A. 2008 Nov 25; 105(47):18372-7.
  10. Countryman RA, Orlowski JD, Brightwell JJ, Oskowitz AZ, Colombo PJ. CREB phosphorylation and c-Fos expression in the hippocampus of rats during acquisition and recall of a socially transmitted food preference. Hippocampus. 2005; 15(1):56-67.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.